Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-02

Clinical Trial Update: The Ultrasound-Guided Dextrose Prolotherapy in Ehlers-Danlos Syndrome Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ultrasound-guided dextrose prolotherapy for Ehlers-Danlos syndrome is listed as not yet recruiting, with associated conditio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ultrasound-guided Dextrose Prolotherapy (dextrose prolotherapy)

Snippet

Sponsor: Tulane University | Conditions: Ehlers-Danlos Syndrome, Low Back Pain | Phase 3 | Status: NOT_YET_RECRUITING